Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vitro evaluation of newly developed chalcone analogues in human cancer cells.
De Vincenzo R, Ferlini C, Distefano M, Gaggini C, Riva A, Bombardelli E, Morazzoni P, Valenti P, Belluti F, Ranelletti FO, Mancuso S, Scambia G. De Vincenzo R, et al. Among authors: ranelletti fo. Cancer Chemother Pharmacol. 2000;46(4):305-12. doi: 10.1007/s002800000160. Cancer Chemother Pharmacol. 2000. PMID: 11052628
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites.
Scambia G, Ranelletti FO, Benedetti Panici P, Piantelli M, Bonanno G, De Vincenzo R, Ferrandina G, Pierelli L, Capelli A, Mancuso S. Scambia G, et al. Among authors: ranelletti fo. Cancer Chemother Pharmacol. 1991;28(4):255-8. doi: 10.1007/BF00685531. Cancer Chemother Pharmacol. 1991. PMID: 1879042
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance.
Ferlini C, Raspaglio G, Mozzetti S, Distefano M, Filippetti F, Martinelli E, Ferrandina G, Gallo D, Ranelletti FO, Scambia G. Ferlini C, et al. Among authors: ranelletti fo. Mol Pharmacol. 2003 Jul;64(1):51-8. doi: 10.1124/mol.64.1.51. Mol Pharmacol. 2003. PMID: 12815160
Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors.
Ferrandina G, Almadori G, Maggiano N, Lanza P, Ferlini C, Cattani P, Piantelli M, Scambia G, Ranelletti FO. Ferrandina G, et al. Among authors: ranelletti fo. Int J Cancer. 1998 Aug 31;77(5):747-54. doi: 10.1002/(sici)1097-0215(19980831)77:5<747::aid-ijc14>3.0.co;2-z. Int J Cancer. 1998. PMID: 9688309
170 results